Singapore markets closed

LENSAR, Inc. (LNSR)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
4.3000-0.3400 (-7.33%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close4.6400
Open4.8000
Bid0.0000 x 0
Ask0.0000 x 0
Day's range4.3000 - 4.8700
52-week range1.8000 - 5.3000
Volume11,090
Avg. volume39,906
Market cap49.007M
Beta (5Y monthly)0.49
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    ORLANDO, Fla., June 03, 2024--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or the "Company") today announced that a majority of the independent members of LENSAR’s board of directors granted three newly-hired non-executive employees stock options to purchase an aggregate of 2,150 shares of the Company’s common stock. The options were granted as of June 3, 2024, as inducements material to each employee entering into employment with the Company. The options were granted in accordance with Nasdaq Listing

  • Business Wire

    LENSAR to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference

    ORLANDO, Fla., May 23, 2024--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of cataracts, today announced that Nick Curtis, Chief Executive Officer, will participate in a Fireside Chat at the 2024 Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024, at 1:40 p.m. CT in Austin, TX.

  • Business Wire

    LENSAR Reports First Quarter 2024 Results and Provides Business Update

    ORLANDO, Fla., May 09, 2024--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of cataracts, today announced financial results for the quarter ended March 31, 2024 and provided an update on key operational initiatives.